2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Biosergen AS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection BSG005 - Invasive Fungal Infection | Phase 1 / Phase 2 | Unknown | Biosergen AS | 15 | 2024-07-01 | 2025-04-06 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005. BSG005 or placebo - Invasive Fungal Infections | Phase 1 | Unknown | Biosergen AS | 72 | 2021-08-23 | 2022-11-21 |
Invasive Fungal Infections (2)
Australia (1) · India (1)
Philippe Ryan, MD (1) · Tine Olesen, PhD (1)